The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor.
Abstract
Androgens play an important role in the regulation of bone metabolism in animals and humans. The present study was performed to investigate whether androgens would affect osteoclast formation stimulated by parathyroid hormone (PTH) in mouse bone cell cultures and its mechanism. Testosterone as well as α‐dihydrotestosterone (DHT) concentration‐dependently inhibited osteoclast formation induced by PTH‐(1‐34). 10−8 M ICI 182780, an estrogen receptor inhibitor, did not affect PTH‐induced osteoclast formation antagonized by 10−8 M testosterone, although it completely antagonized the effects of 10−8 M 17β‐estradiol. Moreover, 3 μM 4‐androsten‐4‐ol‐3,17‐dione, an aromatase inhibitor, did not affect PTH‐induced osteoclast formation antagonized by testosterone. Hydroxyflutamide, an androgen receptor antagonist, concentration‐dependently antagonized the inhibitory effects of testosterone as well as DHT on PTH‐stimulated osteoclast formation. In conclusion, the present study first demonstrated that testosterone inhibited osteoclast formation stimulated by PTH through the androgen receptor, but not through the production of intrinsic estrogen in mouse bone cell cultures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Androgens also suppress osteoclastogenesis in coculture model systems that are dependent on osteoblasts (217).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [217]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O'Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 659
Identification of androgen receptors in normal human osteoblast-like cells.
Colvard, D. S., Eriksen, E. F., Keeting, P. E., Wilson, E. M., Lubahn, D. B., French, F. S., Riggs, B. L., & Spelsberg, T. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.854 · Cited by 462
Slemenda, C. W., Longcope, C., Zhou, L., Hui, S. L., Peacock, M., & Johnston, C. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119701 · Cited by 455
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
FINKELSTEIN, J. S., KLIBANSKI, A., NEER, R. M., GREENSPAN, S. L., ROSENTHAL, D. I., & CROWLEY, W. F. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3- · Cited by 408
ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE CELLS IN VITRO
Kasperk, C. H., Wergedal, J. E., Farley, J. R., Linkhart, T. A., Turner, R. T., & Baylink (1989) · Endocrinology · doi:10.1210/endo-124-3-1576 · Cited by 399
ORWOLL, E. S., & KLEIN, R. F. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-87 · Cited by 335
Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency
Vanderschueren, D. (1992) · Endocrinology · doi:10.1210/en.130.5.2906 · Cited by 222
Androgen treatment prevents loss of cancellous bone in the orchidectomized rat
Wakley, G. K., Schutte, H. D., Hannon, K. S., & Turner, R. T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060403 · Cited by 190
Vanderschueren, D., & Bouillon, R. (1995) · Calcified Tissue International · doi:10.1007/bf00301598 · Cited by 159
Research works printed but not linked: 2
- 10.1210/endo.130.5.1572302 · doi:10.1210/endo.130.5.1572302 · Paper page
- 10.1210/en.137.6.2217 · doi:10.1210/en.137.6.2217
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Michael, H., Härkönen, P. L., Väänänen, H. K., & Hentunen, T. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050803 · Cited by 200
Androgens suppress osteoclast formation induced by RANKL and macrophage colony-stimulating factor.
Huber, D. M., Bendixen, A. C., Pathrose, P., Srivastava, S., Dienger, K. M., Shevde, N. K., & Pike, J. W. (2001) · Endocrinology · doi:10.1210/endo.142.9.8402 · Cited by 141
“These studies support findings that both E and androgens function to protect bone in males and females (7, 11, 22, 38).”
Notini, A. J., McManus, J. F., Moore, A., Bouxsein, M., Jimenez, M., Chiu, W. M., Glatt, V., Kream, B. E., Handelsman, D. J., Morris, H. A., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061117 · Cited by 148
Hanada, K., Furuya, K., Yamamoto, N., Nejishima, H., Ichikawa, K., Nakamura, T., Miyakawa, M., Amano, S., Sumita, Y., & Oguro, N. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1563 · Cited by 132
Metadata
- Authors
- Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K.
- Affiliations
- Kobe University (JP)
- Corresponding author
- Sugimoto, Toshitsugu
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2001-02-20
- Volume
- 491
- Issue
- 1-2
- Pages
- 91-93
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1968430611
- Cited by
- 63
- References
- 20
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 4 · 2022: 1 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- testosterone, osteoclastogenesis, parathyroid hormone, androgen receptor, bone metabolism, estrogen receptor, aromatase, hydroxyflutamide, bone cell culture
- MeSH terms
- Fulvestrant, Androgen Antagonists, Androstenedione, Animals, Cell Division, Cells, Cultured, Enzyme Inhibitors, Estradiol, Estrogen Antagonists, Flutamide, Glucuronates, Mice, Inbred ICR, Osteoclasts, Parathyroid Hormone, Receptors, Androgen, Dihydrotestosterone, Testosterone, Teriparatide, Aromatase Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. https://app.cochat.ai/papers/10.1016/s0014-5793(01)02160-3
- The paper
- Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K. (2001). Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. FEBS Letters. https://doi.org/10.1016/s0014-5793(01)02160-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.